International trade · 26/01/2011Updated: 10/17/2026 · 1 min read
U.S. International Trade Commission Seeks Comments on Gemcitabine Complaint
Summary
The U.S. International Trade Commission has received a complaint about gemcitabine and is now seeking public comments on any issues related to the public interest.